STOCK TITAN

[Form 4] Durect Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

James E. Brown, President & CEO and a director of DURECT Corporation (DRRX), reported acquisitions on 09/08/2025. The filing shows an acquisition of 10,000 common shares at a reported price of $1.30, bringing his direct common stock holdings to 283,412 shares. The filing also reports an acquisition of 10,000 stock options with a $1.30 exercise/conversion price, noting an exercisable/expiration schedule with a reference date of 10/14/2034 and total direct derivative holdings reported as 365,000. The option grant will vest in one‑sixteenth increments every three months, subject to continued service.

James E. Brown, Presidente e CEO nonché amministratore di DURECT Corporation (DRRX), ha comunicato acquisti effettuati il 08/09/2025. La dichiarazione riporta l'acquisto di 10.000 azioni ordinarie a un prezzo unitario di $1,30, portando la sua partecipazione diretta in azioni ordinarie a 283.412 azioni. Viene inoltre segnalato l'acquisto di 10.000 opzioni con prezzo di esercizio/conversione di $1,30, con un piano esercitabile/scadenza con data di riferimento 14/10/2034 e un totale di strumenti derivati diretti dichiarati pari a 365.000. Le opzioni matureranno in tranche di un sedicesimo ogni tre mesi, subordinatamente alla continuazione del rapporto di servizio.

James E. Brown, presidente y CEO y miembro del consejo de DURECT Corporation (DRRX), informó adquisiciones el 08/09/2025. El informe muestra la compra de 10.000 acciones ordinarias a un precio informado de $1,30, elevando su participación directa en acciones ordinarias a 283.412 acciones. El documento también registra la adquisición de 10.000 opciones con un precio de ejercicio/conversión de $1,30, indicando un cronograma ejercitable/de vencimiento con fecha de referencia 14/10/2034 y un total de participaciones derivadas directas declaradas de 365.000. Las opciones se consolidarán en incrementos de una dieciseisava parte cada tres meses, sujeto a la continuidad del servicio.

James E. Brown는 DURECT Corporation(DRRX)의 회장 겸 CEO이자 이사로서 2025-09-08에 보유 주식 취득을 신고했습니다. 제출서류에 따르면 10,000 보통주를 주당 $1.30에 취득하여 직접 보유한 보통주 수가 283,412주가 되었습니다. 또한 행사가/전환가액이 $1.3010,000 주식옵션 취득도 보고되었으며, 행사 가능/만료 일정의 기준일은 2034-10-14이고 직접 파생상품 총 보유량은 365,000으로 기재되어 있습니다. 이 옵션은 근속을 조건으로 3개월마다 1/16씩 베스팅됩니다.

James E. Brown, président-directeur général et administrateur de DURECT Corporation (DRRX), a déclaré des acquisitions le 08/09/2025. Le dépôt fait état de l'achat de 10 000 actions ordinaires à un prix déclaré de 1,30 $, portant sa détention directe d'actions ordinaires à 283 412 actions. Le dossier signale également l'acquisition de 10 000 options au prix d'exercice/de conversion de 1,30 $, précisant un calendrier d'exercice/d'expiration avec une date de référence au 14/10/2034 et un total d'instruments dérivés directs déclarés de 365 000. La levée des options s'effectuera par tranches de un seizième tous les trois mois, sous réserve de la continuité du service.

James E. Brown, Präsident & CEO sowie Direktor von DURECT Corporation (DRRX), meldete Erwerbe zum 08.09.2025. Die Einreichung weist den Erwerb von 10.000 Stammaktien zu einem angegebenen Preis von $1,30 aus, wodurch sein direkter Stammaktienbestand auf 283.412 Aktien anstieg. Ebenfalls gemeldet wurde der Erwerb von 10.000 Aktienoptionen mit einem Ausübungs-/Umwandlungspreis von $1,30, mit einem ausübbaren/ablaufbezogenen Zeitplan und Referenzdatum 14.10.2034 sowie einem gemeldeten Gesamtbestand an direkten derivativen Positionen von 365.000. Die Optionszuteilung wird in Sechzehntel-Schritten alle drei Monate unverfallbar, vorbehaltlich fortgesetzter Dienstzeit.

Positive
  • Insider acquisition: Reporting person acquired 10,000 common shares on 09/08/2025, increasing reported direct ownership to 283,412 shares.
  • Option grant reported: Reporting person received 10,000 stock options with a stated $1.30 exercise/conversion price and vesting schedule, increasing reported derivative holdings to 365,000.
  • Vesting ties to service: Options vest in one‑sixteenth increments every three months, aligning incentives with continued employment.
Negative
  • None.

Insights

TL;DR: Insider reported small net purchase of stock and options, indicating continued executive ownership rather than a material stake change.

The Form 4 documents a same‑day acquisition of 10,000 common shares and 10,000 options at $1.30, increasing reported direct common holdings to 283,412 and direct derivative holdings to 365,000. The absolute size of the purchases is modest relative to the reported holdings, so this is not a material reshaping of ownership. The option vesting schedule—one‑sixteenth every three months—ties value to continued service, aligning executive incentives with future performance.

TL;DR: Transaction reflects routine executive compensation/ownership activity with standard time‑based vesting conditions.

The filing identifies James E. Brown as both President & CEO and a director, and documents acquisitions that appear tied to compensation (vesting schedule described). The explicit quarterly vesting over multiple periods underscores a retention design. There are no disclosures here of significant disposals, accelerated vesting, or related‑party transfers that would raise governance concerns.

James E. Brown, Presidente e CEO nonché amministratore di DURECT Corporation (DRRX), ha comunicato acquisti effettuati il 08/09/2025. La dichiarazione riporta l'acquisto di 10.000 azioni ordinarie a un prezzo unitario di $1,30, portando la sua partecipazione diretta in azioni ordinarie a 283.412 azioni. Viene inoltre segnalato l'acquisto di 10.000 opzioni con prezzo di esercizio/conversione di $1,30, con un piano esercitabile/scadenza con data di riferimento 14/10/2034 e un totale di strumenti derivati diretti dichiarati pari a 365.000. Le opzioni matureranno in tranche di un sedicesimo ogni tre mesi, subordinatamente alla continuazione del rapporto di servizio.

James E. Brown, presidente y CEO y miembro del consejo de DURECT Corporation (DRRX), informó adquisiciones el 08/09/2025. El informe muestra la compra de 10.000 acciones ordinarias a un precio informado de $1,30, elevando su participación directa en acciones ordinarias a 283.412 acciones. El documento también registra la adquisición de 10.000 opciones con un precio de ejercicio/conversión de $1,30, indicando un cronograma ejercitable/de vencimiento con fecha de referencia 14/10/2034 y un total de participaciones derivadas directas declaradas de 365.000. Las opciones se consolidarán en incrementos de una dieciseisava parte cada tres meses, sujeto a la continuidad del servicio.

James E. Brown는 DURECT Corporation(DRRX)의 회장 겸 CEO이자 이사로서 2025-09-08에 보유 주식 취득을 신고했습니다. 제출서류에 따르면 10,000 보통주를 주당 $1.30에 취득하여 직접 보유한 보통주 수가 283,412주가 되었습니다. 또한 행사가/전환가액이 $1.3010,000 주식옵션 취득도 보고되었으며, 행사 가능/만료 일정의 기준일은 2034-10-14이고 직접 파생상품 총 보유량은 365,000으로 기재되어 있습니다. 이 옵션은 근속을 조건으로 3개월마다 1/16씩 베스팅됩니다.

James E. Brown, président-directeur général et administrateur de DURECT Corporation (DRRX), a déclaré des acquisitions le 08/09/2025. Le dépôt fait état de l'achat de 10 000 actions ordinaires à un prix déclaré de 1,30 $, portant sa détention directe d'actions ordinaires à 283 412 actions. Le dossier signale également l'acquisition de 10 000 options au prix d'exercice/de conversion de 1,30 $, précisant un calendrier d'exercice/d'expiration avec une date de référence au 14/10/2034 et un total d'instruments dérivés directs déclarés de 365 000. La levée des options s'effectuera par tranches de un seizième tous les trois mois, sous réserve de la continuité du service.

James E. Brown, Präsident & CEO sowie Direktor von DURECT Corporation (DRRX), meldete Erwerbe zum 08.09.2025. Die Einreichung weist den Erwerb von 10.000 Stammaktien zu einem angegebenen Preis von $1,30 aus, wodurch sein direkter Stammaktienbestand auf 283.412 Aktien anstieg. Ebenfalls gemeldet wurde der Erwerb von 10.000 Aktienoptionen mit einem Ausübungs-/Umwandlungspreis von $1,30, mit einem ausübbaren/ablaufbezogenen Zeitplan und Referenzdatum 14.10.2034 sowie einem gemeldeten Gesamtbestand an direkten derivativen Positionen von 365.000. Die Optionszuteilung wird in Sechzehntel-Schritten alle drei Monate unverfallbar, vorbehaltlich fortgesetzter Dienstzeit.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BROWN JAMES E

(Last) (First) (Middle)
C/O DURECT CORPORATION
10240 BUBB ROAD

(Street)
CUPERTINO CA 95014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DURECT CORP [ DRRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/08/2025 M 10,000 A $1.3 283,412 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $1.3 09/08/2025 M 10,000 (1) 10/14/2034 Common Stock 10,000 $0 365,000 D
Explanation of Responses:
1. The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three-month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.
/s/ James E. Brown 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for DRRX?

The Form 4 was filed by James E. Brown, President & CEO and a director of DURECT Corporation (DRRX).

What transactions were reported on the DRRX Form 4 dated 09/08/2025?

The filing reports acquisition of 10,000 common shares at $1.30 and acquisition of 10,000 stock options with a $1.30 conversion/exercise price on 09/08/2025.

How many DRRX shares does James E. Brown beneficially own after the reported transactions?

Following the reported transactions, the Form 4 lists 283,412 common shares beneficially owned directly by the reporting person.

What are the terms of the option vesting reported in the DRRX Form 4?

The option will vest and become exercisable in installments of one‑sixteenth (1/16) of the total number of shares at the end of each three‑month period following the grant date, subject to continuous service.

When was the Form 4 signed?

The filing shows the reporting person signed the Form 4 on 09/09/2025.
DURECT

NASDAQ:DRRX

DRRX Rankings

DRRX Latest News

DRRX Latest SEC Filings

DRRX Stock Data

59.31M
27.26M
12.67%
23.58%
1.11%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CUPERTINO